120 related articles for article (PubMed ID: 27099884)
1. Comment on "Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction".
Oliveira M
Rev Port Cardiol; 2015 Dec; 34(12):795-7. PubMed ID: 27099884
[TBL] [Abstract][Full Text] [Related]
2. Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction.
Abraham WT; Zile MR; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC
JACC Heart Fail; 2015 Jun; 3(6):487-496. PubMed ID: 25982108
[TBL] [Abstract][Full Text] [Related]
3. Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.
Zile MR; Abraham WT; Weaver FA; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Little WC
Eur J Heart Fail; 2015 Oct; 17(10):1066-74. PubMed ID: 26011593
[TBL] [Abstract][Full Text] [Related]
4. Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
Zile MR; Lindenfeld J; Weaver FA; Zannad F; Galle E; Rogers T; Abraham WT
J Am Coll Cardiol; 2020 Jul; 76(1):1-13. PubMed ID: 32616150
[TBL] [Abstract][Full Text] [Related]
5. Response by Sex in Patient-Centered Outcomes With Baroreflex Activation Therapy in Systolic Heart Failure.
Lindenfeld J; Gupta R; Grazette L; Ruddy JM; Tsao L; Galle E; Rogers T; Sears S; Zannad F
JACC Heart Fail; 2021 Jun; 9(6):430-438. PubMed ID: 33992562
[TBL] [Abstract][Full Text] [Related]
6. Baroreflex activation therapy in patients with heart failure and a reduced ejection fraction: Long-term outcomes.
Zile MR; Lindenfeld J; Weaver FA; Zannad F; Galle E; Rogers T; Abraham WT
Eur J Heart Fail; 2024 Apr; 26(4):1051-1061. PubMed ID: 38606555
[TBL] [Abstract][Full Text] [Related]
7. Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease.
Halbach M; Abraham WT; Butter C; Ducharme A; Klug D; Little WC; Reuter H; Schafer JE; Senni M; Swarup V; Wachter R; Weaver FA; Wilks SJ; Zile MR; Müller-Ehmsen J
Int J Cardiol; 2018 Sep; 266():187-192. PubMed ID: 29705650
[TBL] [Abstract][Full Text] [Related]
8. Baroreflex activation therapy with the Barostim™ device in patients with heart failure with reduced ejection fraction: a patient level meta-analysis of randomized controlled trials.
Coats AJS; Abraham WT; Zile MR; Lindenfeld JA; Weaver FA; Fudim M; Bauersachs J; Duval S; Galle E; Zannad F
Eur J Heart Fail; 2022 Sep; 24(9):1665-1673. PubMed ID: 35713888
[TBL] [Abstract][Full Text] [Related]
9. First granted example of novel FDA trial design under Expedited Access Pathway for premarket approval: BeAT-HF.
Zile MR; Abraham WT; Lindenfeld J; Weaver FA; Zannad F; Graves T; Rogers T; Galle EG
Am Heart J; 2018 Oct; 204():139-150. PubMed ID: 30118942
[TBL] [Abstract][Full Text] [Related]
10. Surgical Experience and Long-term Results of Baroreflex Activation Therapy for Heart Failure With Reduced Ejection Fraction.
Weaver FA; Abraham WT; Little WC; Butter C; Ducharme A; Halbach M; Klug D; Lovett EG; Madershahian N; Müller-Ehmsen J; Schafer JE; Senni M; Swarup V; Wachter R; Zile MR
Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):320-328. PubMed ID: 28043438
[TBL] [Abstract][Full Text] [Related]
11. Baroreflex activation therapy in patients with heart failure with reduced ejection fraction: a single-centre experience.
Blanco C; Madej T; Mangner N; Hommel J; Grimm S; Knaut M; Linke A; Winzer EB
ESC Heart Fail; 2023 Dec; 10(6):3373-3384. PubMed ID: 37667319
[TBL] [Abstract][Full Text] [Related]
12. [Baroreflex activation therapy. A novel interventional approach to treat heart failure with reduced ejection fraction].
Halbach M; Fritz T; Madershahian N; Pfister R; Reuter H
Herz; 2015 Nov; 40(7):959-65. PubMed ID: 26525523
[TBL] [Abstract][Full Text] [Related]
13. Cardiac Contractility Modulation and Baroreflex Activation Therapy in Heart Failure Patients.
Mann JA; Abraham WT
Curr Heart Fail Rep; 2019 Feb; 16(1):38-46. PubMed ID: 30762177
[TBL] [Abstract][Full Text] [Related]
14. Cost-impact analysis of baroreflex activation therapy in chronic heart failure patients in the United States.
Bisognano J; Schneider JE; Davies S; Ohsfeldt RL; Galle E; Stojanovic I; Deering TF; Lindenfeld J; Zile MR
BMC Cardiovasc Disord; 2021 Mar; 21(1):155. PubMed ID: 33771104
[TBL] [Abstract][Full Text] [Related]
15. Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study.
Gronda E; Seravalle G; Brambilla G; Costantino G; Casini A; Alsheraei A; Lovett EG; Mancia G; Grassi G
Eur J Heart Fail; 2014 Sep; 16(9):977-83. PubMed ID: 25067799
[TBL] [Abstract][Full Text] [Related]
16. Autonomic Modulation With Baroreflex Activation Therapy in Heart Failure.
Gronda E; Vanoli E
Curr Heart Fail Rep; 2016 Dec; 13(6):273-280. PubMed ID: 27854009
[TBL] [Abstract][Full Text] [Related]
17. Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report.
Dell'Oro R; Gronda E; Seravalle G; Costantino G; Alberti L; Baronio B; Staine T; Vanoli E; Mancia G; Grassi G
J Hypertens; 2017 Dec; 35(12):2532-2536. PubMed ID: 28816745
[TBL] [Abstract][Full Text] [Related]
18. Effects of chronic carotid baroreceptor activation on arterial stiffness in severe heart failure.
Gronda E; Brambilla G; Seravalle G; Maloberti A; Cairo M; Costantino G; Lovett E; Vanoli E; Mancia G; Grassi G
Clin Res Cardiol; 2016 Oct; 105(10):838-46. PubMed ID: 27120329
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction.
Givertz MM; Stevenson LW; Costanzo MR; Bourge RC; Bauman JG; Ginn G; Abraham WT;
J Am Coll Cardiol; 2017 Oct; 70(15):1875-1886. PubMed ID: 28982501
[TBL] [Abstract][Full Text] [Related]
20. Baroreflex activation therapy: a new treatment option for heart failure with reduced ejection fraction.
Halbach M; Hickethier T; Madershahian N; Müller-Ehmsen J
Expert Rev Cardiovasc Ther; 2014 Dec; 12(12):1465-9. PubMed ID: 25382103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
